Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.
作者信息
Novoselac A V, Reddy S, Sanmugarajah J
出版信息
Leukemia. 2004 Sep;18(9):1561-2. doi: 10.1038/sj.leu.2403417.
PMID:15215874
Abstract
摘要
相似文献
1
Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.米托蒽醌治疗后多发性硬化症患者发生急性早幼粒细胞白血病。
Leukemia. 2004 Sep;18(9):1561-2. doi: 10.1038/sj.leu.2403417.
2
A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.米托蒽醌治疗多发性硬化症后发生急性早幼粒细胞白血病1例。
Leukemia. 2003 May;17(5):985-6. doi: 10.1038/sj.leu.2402887.
3
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.米托蒽醌治疗多发性硬化症后发生的急性早幼粒细胞白血病。
Cancer Genet Cytogenet. 2008 Apr 15;182(2):126-9. doi: 10.1016/j.cancergencyto.2008.01.004.
4
Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis.两例多发性硬化症患者在接受米托蒽醌治疗后发生急性早幼粒细胞白血病的新病例。
Leukemia. 2006 Dec;20(12):2217-8. doi: 10.1038/sj.leu.2404443. Epub 2006 Oct 19.
5
Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.三氧化二砷在米托蒽醌治疗多发性硬化后发生的继发性急性早幼粒细胞白血病中的应用。
Leuk Lymphoma. 2009 Jul;50(7):1217-8. doi: 10.1080/10428190902912486.
6
Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.米托蒽醌治疗多发性硬化症后发生急性早幼粒细胞白血病累及视神经。
J Neurol Sci. 2008 Oct 15;273(1-2):144-7. doi: 10.1016/j.jns.2008.06.028. Epub 2008 Aug 6.
7
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.多发性硬化症中急性早幼粒细胞白血病的风险：DNA 修复基因的编码变异。
Neurology. 2011 Mar 22;76(12):1059-65. doi: 10.1212/WNL.0b013e318211c3c8. Epub 2011 Feb 23.
8
Mitoxantrone-related acute leukemia in two MS patients.
Acta Neurol Belg. 2008 Sep;108(3):99-102.
9
Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?米托蒽醌相关的治疗相关性急性白血病：风险是什么，我们能否将其降至最低？
Mult Scler. 2009 Apr;15(4):505-8. doi: 10.1177/1352458508100967. Epub 2009 Feb 27.
10
Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.米托蒽醌单药治疗多发性硬化后发生急性早幼粒细胞白血病。
Leukemia. 1998 Mar;12(3):441-2. doi: 10.1038/sj.leu.2400915.
引用本文的文献
1
Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.基于同时抑制乳腺癌耐药蛋白（BCRP）和Bcl-2的三合一多功能脂质-甘氨胆酸钠纳米载体对盐酸米托蒽醌多药耐药性的协同和完全逆转
Int J Nanomedicine. 2016 Aug 23;11:4077-91. doi: 10.2147/IJN.S95767. eCollection 2016.
2
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.为期5年的IV期RENEW（评估诺华妥对恶化型多发性硬化症疗效的注册研究）研究结果。
BMC Neurol. 2013 Jul 11;13:80. doi: 10.1186/1471-2377-13-80.
3
Acute myeloid leukemia developing in patients with autoimmune diseases.自身免疫性疾病相关的急性髓系白血病。
Haematologica. 2012 Jun;97(6):805-17. doi: 10.3324/haematol.2011.056283. Epub 2011 Dec 16.
4
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.多发性硬化症治疗后发生的继发性急性早幼粒细胞白血病中t(15;17)基因组断点的分子分析。
Blood. 2008 Oct 15;112(8):3383-90. doi: 10.1182/blood-2007-10-115600. Epub 2008 Jul 23.
5
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.米托蒽醌治疗侵袭性多发性硬化症诱发的急性髓系白血病。
Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
Zotero 插件